Boehringer Ingelheim hepatitis C clinical trials

• Germany
• Healthcare
• Pharma & Biotech
• Science

950 treatment naïve genotype-1b patients enrolled for two of Boehringer Ingelheim pivotal Phase III interferon-free hepatitis C clinical trials

Over 950 patients have now been successfully enrolled in the pivotal Phase III HCVerso™1 and 2 trials The Phase III…